Earnings Forecast Research on Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics, Inc. has received $-1.13 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 6 Financial Advisor in the Stock Trading Firms. Among 6 Analysts, Bottom line EPS Estimate for the current quarter is $-1.3 while the top line estimate is $-0.88 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at -29.5%.

Heron Therapeutics, Inc. results fell short with a surprise EPS of -8.77% or $-0.1. The Actual EPS was $-1.24 compared to the Estimated EPS of $-1.14 during its most recent quarterly earnings. Redwood City based Heron Therapeutics, Inc. Last reported the Quarter results on Dec 31, 2016 and the Next earnings date is scheduled to be released on Feb 17, 2017.

In the last quarter, Heron Therapeutics, Inc. reported Annual Earnings of $-1.24. Based on the filings, last years Annual Earnings was, $-2.95. In the last Quarter, HRTX reported a surprise Earnings per Share of -8.77% . The consensus estimate for current quarter is $-1.13 and for the current fiscal year, the estimate is $-4.48. For the Next fiscal year, the estimate is $-3.94 based on the consensus.

Heron Therapeutics, Inc. (NASDAQ:HRTX) : On Tuesday heightened volatility was witnessed in Heron Therapeutics, Inc. (NASDAQ:HRTX) which led to swings in the share price. The stock opened for trading at $12.55 and hit $13.05 on the upside , eventually ending the session at $13, with a gain of 3.59% or 0.45 points. The heightened volatility saw the trading volume jump to 1,531,578 shares. The 52-week high of the share price is $25.46 and the company has a market cap of $669 million. The 52-week low of the share price is at $12.2135 .

Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.


Share this post

Leave a Reply